Health Beliefs, Behaviors, and Healthcare Experiences Among United States Young and Mid-Age Adults

Health Beliefs, Behaviors, and Healthcare Experiences Among a National Sample of United States Young and Mid-Age Adults

The study will provide important insight into current HPV vaccine knowledge/awareness, health beliefs, affect, vaccine discussions, decision preparedness, and vaccine intentions and behaviors among those ages 18-45, while examining potential differences in responses between those ages 18-26 and those ages 27-45 and vaccinated and unvaccinated individuals.

Study Overview

• Status: Completed
• Conditions: HPV Vaccine Knowledge
• Intervention / Treatment: Behavioral: Survey

Detailed Description

The study will provide important insight into current HPV vaccine knowledge/awareness, health beliefs, affect, vaccine discussions, decision preparedness, and vaccine intentions and behaviors among those ages 18-45, while examining potential differences in responses between those ages 18-26 and those ages 27-45 and vaccinated and unvaccinated individuals. In addition, the study will illuminate gaps in knowledge and awareness as well as the education intervention preferences (e.g., intervention platform, source of information, timing of intervention) of individuals ages 18-45. Among those ages 27-45, shared clinical decision-making is recommended. Compared to individuals ages 18-26, individuals ages 27-45 may need to be supported uniquely so that they are prepared to engage in shared clinical decision-making about HPV vaccination with their healthcare provider. Thus, among unvaccinated individuals ages 27-45, for whom shared clinical decision-making is recommended, preparedness for engagement in shared clinical decision-making will be assessed and explored. The study also will allow investigators to identify how best to target information to young adults and mid-adults both for themselves, and among those with children, for their children.

• Study Type: Observational
• Enrollment (Actual): 4000

Contacts and Locations

Study Locations

• United States
  • Florida
    • Tampa, Florida, United States, 33612
      • Moffitt Cancer Center

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 45 years (Adult)
• Accepts Healthy Volunteers: N/A
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Participants living throughout the United States

Description

Inclusion Criteria:

• Age 18-45
• Living in the United States
• a KnowledgePanel panelist directly or via verified partners
• Have internet access
• Able to read, write and understand English
• Individuals can participant regardless of their HPV vaccination status

Exclusion Criteria:

• Individuals who do not meet inclusion criteria

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Males and Females ages 18-26; Participants between the ages of 18-26 will complete a survey	Behavioral: Survey; Data will be obtained via self-report from participants via a one-time Qualtrics survey.
Males and Females ages 27-45; Participants between the ages of 27-45 will complete a survey	Behavioral: Survey; Data will be obtained via self-report from participants via a one-time Qualtrics survey.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
HPV Vaccine Knowledge	Data from survey will describe HPV and HPV vaccine knowledge, health beliefs, attitudes, affect, health literacy, health care experiences, vaccine discussions and information sources, preparedness for shared decision-making and HPV vaccine uptake and intentions and examine relationships between these variables among a national sample of U.S. adults (N=4,000) ages 18-45 years.	Day 1
HPV-Related Educational Intervention Preferences	Data from survey will describe intervention preferences and associations between intervention preferences and sociodemographic variables (e.g., age, gender, race, ethnicity, socioeconomic status, employment status, parental status, and insurance status).	Day 1

Collaborators and Investigators

• Sponsor: H. Lee Moffitt Cancer Center and Research Institute
• Investigators: Principal Investigator: Shannon M Christy, PhD, Moffitt Cancer Center

Study record dates

Study Major Dates

• Study Start (Actual): February 17, 2021
• Primary Completion (Actual): July 6, 2022
• Study Completion (Actual): July 6, 2022

Study Registration Dates

• First Submitted: February 19, 2021
• First Submitted That Met QC Criteria: February 19, 2021
• First Posted (Actual): February 23, 2021

Study Record Updates

• Last Update Posted (Actual): November 3, 2022
• Last Update Submitted That Met QC Criteria: November 2, 2022
• Last Verified: November 1, 2022

More Information

Terms related to this study

• Keywords: HPV; HPV Vaccine
• Other Study ID Numbers: MCC-20853

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No